Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
1 | Adipocytokine signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
2 | AMPK signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
3 | Apelin signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
4 | Autophagy - animal |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
5 | Circadian rhythm |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
6 | Fluid shear stress and atherosclerosis |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
7 | FoxO signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
8 | Glucagon signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
9 | Hypertrophic cardiomyopathy (HCM) |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
10 | Insulin resistance |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
11 | Insulin signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
12 | Longevity regulating pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
13 | Longevity regulating pathway - multiple species |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
14 | mTOR signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
15 | Non-alcoholic fatty liver disease (NAFLD) |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
16 | Oxytocin signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
17 | PI3K-Akt signaling pathway |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
18 | Thermogenesis |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 | |||||
19 | Tight junction |
[2] PRKAA1, PRKAA2 | D00944 | Metformin | [17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |